Introduction

NKT cells express intermediate levels of a semi-invariant
Va14Ja218 TCR in mice and an invariant Va24Ja15 TCR in humans (1) , which recognizes glycolipid antigens presented by CD1d molecules (2) . The a-galactosyl ceramide (a-GalCer) binds to CD1d and these complexes are recognized by the TCR of NKT cells (3) . Upon activation, NKT cells rapidly produce large amounts of IL-4 and IFN-g (4) , which play critical roles in the regulation of immune responses by NKT cells (5) . In animal models, NKT cells have been reported to affect the development and progression of diabetes mellitus (6) , experimental autoimmune encephalitis (7), rheumatoid arthritis (8) , pulmonary fibrosis (9) , and lupus (10) .
NKT cells play an indispensable role in the induction of antibody-induced joint inflammation by suppressing TGF-b1 production in joint tissues, which in turn is dependent on IL-4 and IFN-g secreted by NKT cells (8) . In addition, a-GalCer slightly enhanced arthritis in C57BL/6 (B6) mice of the KRN TCR transgenic mice of C57BL/6 (B6) background × NOD mice (K/BxN; see Methods) serum transfer mouse model, which suggested that TCR engagement on NKT cells may contribute to NKT cell activation in this model. Therefore, we speculated that cellular glycolipids provided by apoptotic cells during the development of arthritis are presented to TCR on NKT cells by CD1d-expressing cells in vivo and thus activate NKT cells to secrete IL-4 and IFN-g. This speculation is supported by several reports that demonstrate that CD1d molecules are able to present cellular glycolipid to activate NKT cells (11) . However, it is unclear whether TCR engagement on NKT cells provides the critical activating signals to NKT cells in the K/BxN serum transfer model. Alternatively, it is feasible that Fcg receptor (FcgR) engagement provides potent activating signals to NKT cells independently of simultaneous TCR stimulation in vivo. Moreover, FcgRIII -/-mice show a slowly progressing arthritis, which suggests that FcgRIII is responsible for the development of antibody-induced arthritis (12, 13) . Unlike conventional T cells, NKT cells are characterized by the expression of FcgRIII, a potent activating receptor on NK cells that contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain (14, 15) . Thus, we hypothesized that IgGs deposited against antigens in joint tissues are recognized by NKT cells through FcgR independently of TCR signals and that the signals generated by FcgR activate NKT cells to produce cytokines and contribute to joint inflammation. To address this hypothesis, we investigated whether FcgR on NKT cells contribute to NKT cell activation in a K/BxN serum transfer model.
Here we show that FcgRIII engagement on NKT cells enhances CD25 and CD69 expression and cytokine production in vitro. Moreover, the adoptive transfer of FcgR-deficient NKT cells does not restore joint inflammation of CD1d -/-mice, whereas wild-type NKT cells induce arthritis in the antibody-induced joint inflammation model. Taken together, these findings indicate that FcgRIII engagement by IgG in joint tissues provides activating signals to NKT cells in antibody-induced arthritis.
Results
NKT cells constitutively express surface FcgRIII.
To investigate the functional roles of FcgR in NKT cell activation in the K/BxN serum transfer model, we explored in detail the expression pattern of FcgR on sorted hepatic NKT cells from B6 mice containing all subpopulations of NKT cells. These hepatic NKT and NK cells expressed FcgRIII mRNA but not FcgRI, -II, or -IV mRNA ( Figure 1A) as detected by RT-PCR, whereas FcgRI, -II, -III, and -IV mRNA was detected in splenocytes. FcgRIII surface expression was confirmed on hepatic NKT and NK cells by flow cytometric analysis using 2.4G2 ( Figure 1B) , a mAb that specifically reacts with FcgRII and -III (16) . To confirm the specific expression of FcgRIII on NKT cells, liver mononuclear cells (MNCs) were preincubated using a Ly17.2 mAb that specifically binds FcgRII molecules and stained using 2.4G2. The fluorescence intensities of 2.4G2 on NK and NKT cells were not reduced by preincubation with Ly17.2 mAb, whereas those on B cells were attenuated ( Figure 1B) . Moreover, the expression of FcgRII molecules was not found on T, NK, or NKT cells, whereas B cells expressed FcgRII on the cell surface. These findings indicate that hepatic NK and NKT cells express FcgRIII but not FcgRII on the cell surface. FcgRIII expression was The expression of CD4/CD8 or Va14 + TCR was analyzed on gated TCRb + 2.4G2 + liver MNCs using anti-CD4 and CD8 mAb or a-GalCer/CD1d dimer. Numbers indicate percent of cells ± SD. (D) Liver MNCs were freshly isolated from B6 mice and cultured with a-GalCer (220 ng/ml) or aggregated IgG (Agg IgG; 10 mg/ml) for 24 hours. FcgRIII expression was analyzed on gated NKT, NK, and T cells. Open histograms represent negative controls, which were stained with anti-NK1.1 and -TCRb mAbs and isotype-matched IgG for 2.4G2. Numbers indicate MFI ± SD. Results are representative of 3 independent experiments. *P < 0.05.
Figure 2
FcgRIII engagement activates NKT cells. (A) Liver MNCs from B6 or FcgR -/-mice were cultured with or without (-) aggregated IgG (10 mg/ml), and CD25 and CD69 expression was analyzed 24 hours after stimulation. Open histograms represent negative controls, in which cells were stained with anti-NK1.1 and -TCRb mAbs and isotype-matched IgG for anti-CD25 or -CD69 mAb. Numbers indicate MFI ± SD, from 3 independent experiments. (B) DN32-D3 cells were stimulated with or without aggregated IgG for 2 hours, lysed, and immunoprecipitated with anti-Syk or -Lyn mAb followed by anti-phosphotyrosine (anti-p-Tyr). The same cell lysates were directly blotted using anti-Syk or -Lyn mAb. Sorted NKT and DN32-D3 cells were stimulated with and without aggregated IgG for 24 hours, and the total proteins were separated by SDS-PAGE and immunoblotted using anti-T-bet or -GATA-3 mAbs. (C) Sorted NKT cells from B6 or FcgR -/-mice (1 × 10 5 cells/well) were stimulated with aggregated IgG for 48 hours. The amounts of IL-4, IFN-g, IL-10, and IL-13 in the culture supernatant were measured using ELISA. (D) Sorted NKT cells from B6 mice (1 × 10 5 cells/well) were cultured with aggregated IgG or anti-CD3 mAb at the indicated concentrations, and the amounts of IL-4, IFN-g, IL-10, and IL-13 measured using ELISA. (E) The same cells as in D were cultured with aggregated IgG (10 mg/ml), anti-CD3 mAb (100 ng/ml), or both for 48 hours. The amounts of IL-4 and IFN-g were measured using ELISA. Results are representative of 3 independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001. lower on hepatic NKT cells than on NK cells. In addition, the expression pattern of FcgR on NKT cells derived from the thymus and spleen was similar to that on NKT cells from the liver as determined by flow cytometric analysis (data not shown). The NKT hybridoma double-negative 32-D3 (DN32-D3) cells expressed FcgRII and -III mRNA but not FcgRI mRNA, as confirmed by flow cytometric analysis (data not shown). The FcgRIII + NKT cells were either CD4 + CD8 -(42.2%) or CD4 -CD8 -(48.2%), whereas CD4 -CD8 + FcgRIII + NKT cells were barely found in the liver. It has been reported that CD4 -CD8 -DN NK1.1 + T cells express FcgRIII but not FcgRII, which is consistent with the FcgR expression pattern on hepatic NKT cells (15) . In addition, 62.3% of FcgRIII + NKT cells were reactive for a-GalCer/CD1d dimer ( Figure 1C ). These findings indicate that FcgRIII + NKT cells are a mixed population of cells that consist of invariant NKT (iNKT) and non-iNKT cells. Taken together, these findings show that NKT cells constitutively express FcgRIII, but not FcgRI, -II, or -IV, on the cell surface in amounts lower than those on NK cells.
Next, to determine whether activating signals through TCR or FcgRIII on NKT cells upregulate FcgRIII expression, liver MNCs isolated from B6 mice were treated with a-GalCer or aggregated IgG in vitro. FcgRIII surface expression on NKT cells was significantly upregulated upon TCR engagement by a-GalCer/CD1d (P < 0.05), whereas FcgRIII surface expression on NK cells or conventional T cells was not enhanced after a-GalCer treatment (P > 0.05; Figure 1D ). In addition, aggregated IgG did not upregulate the expression level of FcgRIII ( Figure 1D ) and TCR (data not shown) on NKT cells. These findings indicate that the constitutive expression of FcgRIII on NKT cell surfaces is upregulated by TCR stimulation.
FcgRIII engagement induces NKT cell activation independently of TCR stimulation. To examine whether FcgRIII engagement activates NKT cells, the expression levels of activating markers such as CD25 and CD69 on NKT, T, and NK cells from B6 and FcgR -/-mice were measured after FcgRIII engagement by aggregated IgG. FcgR -/-mice are deficient in FcgRI, FcgRIII, FcgRIV, and FcεRI expression because the deleted g chain subunit is essential for the cell surface expression of these molecules (17, 18) . Therefore, NKT cells from FcgR -/-mice lack FcgRIII expression on the cell surface. FcgRIII engagement enhanced CD69 and CD25 expression on B6 mouse NKT cells, whereas FcgR -/-mouse NKT cells showed no CD69 or CD25 upregulation ( Figure 2A ). However, noncomplexed IgG did not alter cytokine production or activation marker expression of NKT cells, suggesting that crosslinking of FcgRIII engagement is critical to activate NKT cells through FcgRIII (data not shown). Moreover, aggregated IgG did not upregulate CD69 and CD25 expression on T and NK cells from B6 and FcgR -/-mice ( Figure 2A ).
To investigate whether FcgRIII engagement induces signal transduction enhancement in NKT cells, we measured the phosphorylation status of Syk and Lyn kinases, which are components of the signal transduction through FcgRIII, in DN32-D3 cells after aggregated IgG treatment. FcgRIII engagement results in the tyrosine phosphorylation of ITAM by members of the SRC kinase family, which subsequently recruits cytosolic protein kinases containing the SH2 domain, most notably Syk and Lyn (19, 20) . We found that FcgRIII engagement on DN32-D3 cells increased the phosphorylation of Syk and Lyn in total cell lysates ( Figure 2B ). These findings suggest that FcgRIII engagement provides activating signals to NKT cells through Syk and Lyn phosphorylation.
To functionally evaluate the effects of NKT cells activated through FcgRIII, we measured the amounts of the cytokines produced by NKT cells stimulated with aggregated IgG. FcgRIII engagement significantly enhanced the production of IL-4, IFN-g, IL-10, and IL-13 by NKT cells from B6 mice, whereas NKT cells from FcgR -/-mice showed less production of these cytokines after aggregated IgG treatment ( Figure 2C ). These findings indicate that production of all cytokines in response to aggregated IgG by B6 NKT cells is significantly greater than that of FcgR -/-NKT cells. Consistent with these findings, FcgRIII engagement increased the expression of the transcription factors T-bet and GATA-3 in the sorted NKT cells and DN32-D3 cells ( Figure 2B ), factors critical for the production of Th1/ Th2 cytokines in immune cells (21, 22) . Taken together, these findings demonstrate for the first time to our knowledge that FcgRIII engagement provides potent activating signals to NKT cells independently of simultaneous TCR stimulation and that this engagement results in enhanced cytokine production.
To investigate in more detail the effects of TCR and FcgRIII stimulation on NKT cells, we compared the relative strengths of the activating signals from TCR and FcgRIII on NKT cells by measuring cytokine production after stimulating liver MNCs of B6 mice with anti-CD3 mAb or aggregated IgG. Maximal production of IL-4, IFN-g, IL-10, and IL-13 in NKT cells stimulated with anti-CD3 mAb were higher than those in NKT cells stimulated with aggregated IgG ( Figure 2D ). These findings suggest that the relative strengths of activating signals in NKT cells through TCR engagement appeared stronger than those through FcgRIII engagement in terms of cytokine production. Alternatively, the difference in surface receptor expression of TCR and FcgRIII on NKT cells is also possible to explain the weaker cytokine response following FcgRIII ligation. Nevertheless, FcgRIII engagement provided signaling sufficient to activate NKT cells without the involvement of TCR signals and thus may contribute to the modulation of immune responses in vivo. Next, to explore whether the simultaneous engagement of TCR and FcgRIII exerts effects on NKT cell activation, sorted NKT cells were cultured with suboptimal concentrations of anti-CD3 mAb and/or aggregated IgG, and cytokine production was measured in culture supernatant. When cultured alone, both TCR and FcgRIII engagement activated NKT cells to produce IL-4 and IFN-g. The activation signals through both TCR and FcgRIII on NKT cells enhance cytokine output significantly compared with activation signals through TCR or FcgRIII alone on NKT cells. However, the amount of these cytokines produced by NKT cells activated by simultaneous engagement of TCR and FcgRIII was similar to the total amounts of cytokines produced by NKT cells activated using anti-CD3 mAb or aggregated IgG alone ( Figure 2E) .
The engagement of FcgRIII on NKT cells promotes antibody-induced arthritis. To determine whether the effects of FcgRIII engagement on NKT cells play a critical role in antibody-induced arthritis, we examined joint inflammation in CD1d -/-mice administered NKT cells from B6 or FcgR -/-mice after K/BxN serum transfer. As previously reported, B6 mice showed measurable joint swelling at 4-5 days and maximal swelling at 8-9 days after serum transfer, whereas CD1d -/-mice were resistant to the development of arthritis (8) . However, CD1d -/-mice administered NKT cells from B6 mice showed measurable swelling, like that of B6 mice, and CD1d -/-mice administered NKT cells from FcgR -/-mice showed minimal joint swelling, like that of CD1d -/-mice ( Figure 3, A and B) . Histological examination of the ankle joints of CD1d -/-mice administered NKT cells from B6 mice at day 5 after serum transfer revealed marked neutrophil infiltration of the synovium. In contrast, CD1d -/-mice administered NKT cells from FcgR -/-mice showed mild inflammatory cell infiltration in the ankle joints ( Figure 3B ). To confirm the infiltration of NKT cells in joint tissues, we measured the Va14Ja218 TCR mRNA level in the joint tissues of CD1d -/-mice administered NKT cells from B6 or FcgR -/-mice after K/BxN serum transfer. RT-PCR showed the presence of Va14Ja218 TCR mRNA in the joint tissues of CD1d -/-mice administered NKT cells from B6 and FcgR -/-mice at 10 days after serum injection. The presence of Va14Ja218 TCR mRNA was not demonstrated in CD1d -/-mice ( Figure 3C ). Moreover, real-time PCR demonstrated that the concentration of Va14Ja218 TCR mRNA in the joint tissues of CD1d -/-mice administered B6 mouse NKT cells was similar to that of the joint tissues of CD1d -/-mice administered FcgR -/-mouse NKT cells ( Figure 3C ). Taken together, these results suggest that primarily FcgRIII engagement, rather than TCR engagement, contributes to NKT cell activation in this K/BxN serum transfer model.
To rule out the possibility that the failure in restoration of joint inflammation in CD1d -/-mice administered FcgR -/-mouse NKT cells might be due to a functional defect of FcgR-deficient NKT cells, we examined the functional activity of NKT cells from FcgR -/-mice by measuring hepatic NKT cell numbers in FcgR -/-and WT mice and cytokine production by NKT cells stimulated with aGalCer in both animal types. The numbers of NKT, NK, CD4 + , and CD8 + cells in FcgR -/-mouse livers were similar to those in WT mouse livers ( Figure 4A ). Furthermore, when liver MNCs from FcgR -/-mice were stimulated with a-GalCer, the production of IL-4, IL-10, IL-13, and IFN-g was enhanced, as in MNCs from B6 mice ( Figure 4B ). Consistent with our in vitro experiments, the production of IL-4, IL-10, IL-13, and IFN-g in sera from FcgR -/-mice injected with a-GalCer was also similar to that in sera from WT B6 mice ( Figure 4C ). These findings indicate that FcgR-deficient NKT cells are functionally intact in terms of activation by a-GalCer/CD1d complexes.
To explore the mechanism by which surface FcgRIII on NKT cells contributes to the development of arthritis, we used real-time PCR to measure the levels of IL-4, IFN-g, and TGF-b in the synovia of CD1d -/-mice administered NKT cells from B6 or FcgR -/-mice. Upon K/BxN serum transfer, CD1d -/-mice administered NKT cells from B6 mice showed a reduced level of TGF-b1 on day 10, as did B6 mice, whereas CD1d -/-mice administered NKT cells from FcgR -/-mice showed an elevated level of TGF-b1, as did CD1d -/-mice ( Figure 3D ). Conversely, IFN-g and IL-4 levels were lower in the joint tissues of CD1d -/-mice administered NKT cells from FcgR -/-mice than in those administered NKT cells from B6 mice. In contrast to the levels in the joint tissues, the levels of TGF-b1, IL-4, and IFN-g in the spleen were similar between CD1d -/-mice
Figure 4
FcgR-deficient NKT cells are activated by a-GalCer. (A) Liver MNCs were freshly isolated from B6 or FcgR -/-mice and analyzed for NKT cells by examining NK1.1 and TCRb expression using flow cytometry. The numbers of NK, NKT, CD4 + , and CD8 + cells were also counted. (B) Liver MNCs were freshly isolated from B6 or FcgR -/-mice and cultured with a-GalCer (220 ng/ml) for 48 hours. The amounts of IL-4, IFN-g, IL-10, and IL-13 in the culture supernatants were measured using ELISA. (C) B6 and FcgR -/-mice were injected i.p. with a-GalCer (1 mg in 300 ml PBS). Serum IL-4, IFN-g, IL-10, and IL-13 levels were monitored using ELISA 12 hours after a-GalCer injection. Data are mean ± SD for 3 mice per group. Similar results were obtained from 3 independent experiments. administered NKT cells from B6 and FcgR -/-mice in the K/BxN serum transfer model. These results indicate that FcgRIII engagement on NKT cells by IgG deposited in joint tissues enhances the production of IL-4 and IFN-g, thereby suppressing TGF-b1 production, as previously reported (8) .
Discussion
Our study demonstrates that FcgR-deficient NKT cells induce less antibody-induced arthritis than do NKT cells of wild-type mice, although the expression level of FcgRIII on NKT cells is relatively low. These findings suggest that primarily FcgRIII engagement, rather than TCR engagement, contribute to NKT cell activation in this K/BxN serum transfer model. To address this suggestion, the possibility that FcgR-deficient NKT cells may be functionally defective in activating processes, thereby contributing the failure to induce arthritis in CD1d -/-mice, will need to be examined in future studies. The ability of FcgR-deficient NKT cells stimulated with a-GalCer to induce cytokine production in vitro and in vivo indicates that FcgR-deficient NKT cells are functionally intact in terms of activation by a-GalCer/CD1d complexes ( Figure 4 , B and C). Therefore, it is unlikely that the failure to induce arthritis in CD1d -/-mice injected with FcgR-deficient NKT cells was attributable to functional defects in NKT cells. Alternatively, it may have been the results of a failure of FcgR-deficient NKT cells to infiltrate joint tissues. However, the amount of Va14Ja218 TCR mRNA in joint tissues of CD1d -/-mice administered B6 mouse NKT cells appeared to be similar to that of CD1d -/-mice administered FcgR -/-mouse NKT cells in real-time PCR ( Figure 3C ). FcgRIII + NKT cells in the joint tissues are a mixed population consisting of iNKT and non-iNKT cells. Moreover, the concentration of Va14Ja218 TCR mRNA in the joint tissues reflects the number of iNKT cells but not non-iNKT cells. Therefore, these findings indicate that FcgR-deficient iNKT cells infiltrate the joint tissues during joint inflammation, much as B6 iNKT cells do. However, during K/BxN serum-transferred arthritis, both CD1d -/-and Ja218 -/-mice showed mild inflammatory cell infiltration in ankle joints and surrounding connective tissues compared with wild-type B6 mice, and the in vivo activation of NKT cells using a-GalCer aggravated joint inflammation (8) . These previous results suggest that iNKT cells contribute to the promotion of joint inflammation in the K/BxN serum transfer model more than non-iNKT cells do. Therefore, the resistance to arthritis in the adoptive transfer experiments of FcgR-deficient NKT cells into CD1d -/-mice was probably caused by the failure of NKT cell activation through FcgRIII signals in the joint tissues.
Our present results revealed that FcgRIII engagement by IgG in joint tissues provides activating signals to NKT cells in antibody-induced arthritis. It is generally believed that the engagement of TCR on NKT cells by a-GalCer/CD1d provides primary activating signals for NKT cell activation in vitro and in vivo (3, 5) . Molecules such as CD28, CD40, glucocorticoid-induced TNF receptor, and ICOS provide synergistic activating signals to NKT cells acting as costimulatory factors in the presence of simultaneous TCR engagement and thus modulate Th1/Th2 immune responses in vivo (23) (24) (25) . Unlike these molecules, FcgRIII induced NKT cell activation even in the absence of simultaneous TCR engagement in vitro, suggesting that FcgRIII provides sufficient activating signals to NKT cells independently of TCR signals. The surface molecules expressed on T or NKT cells have not previously been reported to provide signals sufficient to activate these cells without simultaneous TCR engagement. Therefore our study elucidates, for the first time to our knowledge, the crucial role of FcgRIII in NKT cell activation in the absence of simultaneous TCR stimulation in vivo.
Several prior reports demonstrated that FcgR -/-mice are resistant to the induction or spontaneous onset of various autoimmune diseases (13, 26, 27) , and NKT cells are critically involved in the development of these diseases (7, 8, 10) . Those reports suggest that the activating function of FcgRIII on NKT cells might not be confined to antibody-induced joint inflammation, but play critical roles in the development of various immune complex-associated autoimmune diseases.
To our knowledge, the activating process of NKT cells by FcgRIII engagement has never been considered during the development of therapeutic approaches to antibody-induced joint inflammation. In the K/BxN serum transfer model, CSF-1-dependent macrophages induced the expression of inhibitory FcgRIIB on CSF-1-independent effector macrophages, and this resulted in protection from antibody-induced arthritis by intravenous immunoglobulin (IVIG) (28) . These findings suggest that FcgRIIb on immune cells may be responsible for mediating protection by IVIG and further suggest that NKT cells may not be strong candidates for therapeutic approaches using IVIG in a K/BxN serum transfer model. Using combinatorial chemistry approaches, Marino et al. identified a peptide able to bind Ig and to interfere with FcgR recognition (29) . The administration of this peptide to MRL/lpr mice, a lupus animal model, resulted in a remarkable enhancement of survival rate, which suggested that treatment based on the administration of molecules capable of interfering with Ig/receptor recognition could provide notable therapeutic benefit. However, as far as NKT cells are concerned, the role of FcgRIII on NKT cells has not previously been characterized to our knowledge in the development of lupus. Therefore, any potential therapeutic utility of targeting FcgRIII on NKT cells in the treatment of lupus remains unknown and should be studied in the future. Unlike in lupus, a novel therapeutic approach targeted at specifically blocking FcgRIII on NKT cells may be useful for modulating joint inflammation induced by NKT cells in autoantibody-induced arthritis.
In conclusion, the current study reveals that FcgRIII engagement by IgG in joint tissues provides activating signals to NKT cells and thereby promotes antibody-induced joint inflammation.
Flow cytometry. The mAbs used were FITC-conjugated 2.4G2, PE-conjugated anti-mouse CD25, PE-conjugated anti-mouse CD69, FITC-or PE-conjugated anti-mouse NK1.1, CyChrome-conjugated anti-mouse TCR-b, FITC-conjugated anti-mouse CD4, and CyChrome-conjugated anti-mouse CD8 (BD Biosciences). The FcgRII-specific mAb (Ly17.2) was a generous gift from U. Hammerling (Memorial Sloan-Kettering Cancer Center, New York, New York, USA). Cells (1 × 10 6 ) were stained with mAbs for 30 minutes at 4°C.
Western blot. NKT cells sorted from B6 mouse liver and DN32-D3 cells were stimulated with and without heat-aggregated IgG, which was prepared by heating purified IgG at 63°C for 20 minutes. Proteins were eluted using extraction reagent (NE-PER Nuclear and Cytoplasmic Extraction Reagents; Pierce Biotechnology). Proteins were separated on SDS-PAGE and transferred to Nitrocellulose Membranes (Protran; Schleicher & Schuell Bioscience). Visualization was achieved using appropriate secondary Abs coupled to HRP, developed using the Abs indicated in Figure 2B and detected by ECL. Anti-GATA-3, anti-T-bet, anti-Syk, and anti-Lyn antibodies were purchased from Santa Cruz Biotechnology Inc. The antiphosphotyrosine antibody, 4G10, was purchased from Upstate USA Inc.
ELISA. Sorted NKT cells (1 × 10 5 cells/well) were stimulated using the concentrations indicated in Figure 2 , C-E, of anti-CD3 mAb and/or aggregated IgG or a-GalCer for 48 hours. All cytokine ELISA kits were obtained from BD Biosciences, and assays were performed according to the manufacturer's instructions. Standard curves were generated using known amounts of purified murine recombinant IL-4 (rIL-4), rIL-10, rIL-13, or rIFN-g (BD Biosciences). The reaction was stopped with 3 N hydroxy acid, and absorbance was read at 450 nm and 570 nm.
Real-time PCR and RT-PCR analysis.
For quantitative real-time PCR, total RNA was isolated from joint tissue homogenates using an RNeasy kit (QIAGEN) according to the manufacturer's instructions. RNA was reverse transcribed with MMLV-RT Taq polymerase (Koschem) prior to PCR. cDNA (1 mg) was amplified in the presence of a TaqMan universal master mix (PerkinElmer), gene-specific probes, the forward and reverse primers, and water. Gene-specific PCR products were measured using an Applied Biosystems 7500 Sequence Detection System (PerkinElmer, Applied Biosystems), and results for each cytokine were normalized to GAPDH expression. For real-time PCR, the following primers were synthesized by Applied Biosystems: GAPDH forward, TGCACCACCAACTGCTTA, reverse, GGATGCAGGGATGATGTT, and probe, CAGAAGACTGTGGATGGCCCCTC-VIC; IFN-g forward, AGCAACAGCAAGGCGAAAA, reverse, CTGGACCTGTGGGTTGTTGA, and probe, CTCAAACTTGGCAATACTCATGAATGCATC-TAMRA; IL-4 primers used were PrimeScreen Mouse IL-4 Primer Pair and probe, FAM-CTCCGTGCATGGGGTCCCTTC-Black Hole Quencher (BioSource International); TGF-b1 forward, GCAACATGTGGAACTCTACCAGAA, reverse, GACGTCAAAAGACAGCCACTCA, and probe, ACCTTGGTA-ACCGGCTGCTGACCC-TAMRA; Va14Ja218 TCR forward, GTGTG-GTGGGCGATAGAGGT, reverse, ACAACCAGCTGAGTCCCAGC, and probe, FAM-CAGCCTTAGGGAGGCTGCATTTTGG-TAMRA.
For RT-PCR, the following primers were synthesized by Genotech Corp: FcgRI forward, GTTAATTGCCACCAAGGCTGT, reverse, ACCTGTATTCGCCACTGTCC; FcgRII forward, AGTCCAAGCCTGT-CACCATC, reverse, CAGTTTTGGCAGCTTCTTCC; FcgRIII forward, TGACACCCCATCCATCCTAT, reverse, CCCAGGATCTCACTGGGT-TA; FcgRIV forward, ATCTGCTCTAGAAGCATGTGGCAGCTACTA, reverse, CATGCGATAAGAGCTCACTTGTCCTGAGGT; Va14Ja18 TCR forward, CTAAGCACAGCACGCTGCACA, reverse, AGGTATGACAAT-CAGCTGAGTCCC.
Serum transfer and arthritis scoring. Arthritic adult K/BxN mice were bled, and sera were pooled. Recipient mice were injected i.p. with 150 ml of pooled K/BxN sera on days 0 and 2 relative to the first injection. Ankle thickness was measured with a caliper (Manostat). Joint swelling was monitored and scored as follows: 0, no joint swelling, 1, swelling of a single finger joint, 2, mild swelling of a wrist or ankle, and 3, severe swelling of a wrist or ankle.
Adoptive transfer. Liver NKT cells were stained using PE-conjugated anti-NK1.1 and CyChrome-conjugated anti-TCR-b mAbs, and NK1.1 + TCR-b + NKT cells were sorted using FACStar PLUS and CellQuest software (version 3.3; BD) to a purity of >98%. Sorted cells were adoptively transferred into CD1d -/-mice via intravenous injection 1 day before the first injection of K/BxN serum.
Histology. Joints were fixed in 10% formalin, decalcified by 10% EDTA in PBS for 3 days, embedded in paraffin, and sectioned, and tissue sections from knee joints were stained with hematoxylin and eosin.
Synthesis of a-GalCer. a-GalCer was synthesized using the method developed by Kim et al. (30) .
Statistics. Statistical significance was analyzed using the Prism 3.0 program (GraphPad Software). To compare more than 2 groups, the 1-way ANOVA statistical analysis using Tukey test was performed. P values less than 0.05 were considered significant.
